17 February 2011 -- LONDON, UK Sun European Partners, LLP (“Sun European Partners”), the
European adviser to Sun Capital Partners, Inc., announces that one of its affiliates
has completed the acquisition of NextPharma Technologies Holding Ltd.
(“NextPharma”), a global provider of contract manufacturing, product development,
clinical trials and logistics services to the pharmaceutical and biotechnology industry.
Terms of the transaction were not disclosed.
Headquartered in Surrey, UK, NextPharma offers a range of services spanning the
entire drug development, manufacturing and distribution supply chain. The company
is a leading outsourcing partner to the pharmaceutical, biotech and healthcare
industries with seven manufacturing facilities, seven product development centres
and six temperature-controlled storage and distribution sites across Europe and the
U.S.. NextPharma supports more than 200 customers including leading blue chip
pharmaceutical and biotech companies.
Bill Wedlake, CEO of NextPharma commented: “The integrated outsourcing model
offered by NextPharma helps improve client profitability by reducing both the cost
and time to market of the product. This service increases client margins by reducing
the number of supply chain providers and freeing up client resource to concentrate
on their own key strategic strengths of research and marketing. We look forward to
working with Sun European Partners to continue to grow the company and to expand
into innovative new technologies and markets.”
Matthias Gundlach, Vice President of Sun European Partners said: “We are delighted
by this acquisition. NextPharma is well positioned to benefit from the changing face
of the drug industry, in particular using drug development and manufacturing
outsourcing. It provides a good foundation from which to build the business
organically and by acquisitions.”
About Sun European Partners, LLP
Sun European Partners, LLP is the European adviser to Sun Capital Partners, Inc., a
leading U.S.-based private investment firm focused on leveraged buyouts, equity,
debt, and other investments in market-leading companies that can benefit from its in–
house operating professionals and experience. Affiliates of Sun Capital Partners, Inc.
have invested in 260 companies worldwide with combined sales in excess of $40
billion since the inception of Sun Capital Partners, Inc. in the U.S. in 1995. Sun
Capital Partners, Inc. has offices in Boca Raton, Los Angeles, and New York, as well as affiliates with offices in London, Frankfurt, Paris, Luxembourg, Shanghai and Shenzhen. For more information, please visit www.SunEuropeanPartners.com.
+44(0)20 7379 5151